Biomedical Research

The study intends to test the hypothesis that ME/CFS cases and controls have different bacterial, fungal or viral microflora in the oropharynx (mouth and throat regions), lower gastrointestinal tract (gut) and blood in a massive, well-powered study. By rigorously characterizing cases and controls and using state-of-the-art methods for identifying microbes, even currently-unknown ones, the CII will also study patients and controls for evidence of differences in immune system function and metabolic function

4 Replies

  • Only seeing good things in the parts I can take onboard.

  • Brain fog on all that info.

  • Has elements of OMF big data study which is on the most severe

  • PACE trial going backwards and bio research going forward these are exciting times.

You may also like...